Abstract
Systemic sclerosis (SSc) is an autoimmune disease marked by fibrosis of the skin and internal organs, immune dysregulation and vasculopathy. Autologous hematopoietic stem cell transplantation (AHSCT) has been investigated as treatment for patients with severe and progressive SSc. Although patients show great clinical and histopathological improvement of cutaneous fibrosis after transplant…